Skip to main content
. 2017 Dec 11;8(68):112236–112244. doi: 10.18632/oncotarget.23096

Figure 2. Diverse de novo anti-Neu5Gc IgGs repertoire post-ATG.

Figure 2

A. Pie charts of anti-Neu5Gc IgG microarray recognition patterns against each Neu5Gc-glycan in S4 and S5 pre-ATG (M0) and post-ATG (M1) exemplifies increased diversity (each pie faction represents a different Neu5Gc-glycan, demonstrating increased number of Neu5Gc-glycans that are being recognized at M1 compared with M0 in each sera, reflected by increased number of pie fractions in M1). B. S4 and S5 RFU divided to common underlying core-glycan-structures demonstrate de novo recognition of additional Neu5Gc-glycans with strongly increased intensities.